Tempus Ai Cl A (TEM)

$42.59 -0.31 (-0.72%)
Market Cap 7.71B
Revenue (ttm) 1.27B
Net Income (ttm) -245.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.27%
Debt to Equity Ratio 0.73
Volume 2,345,903
Avg Vol 6,296,374
Day's Range N/A - N/A
Shares Out 179.57M
Stochastic %K 12%
Beta 3.46
Analysts Sell
Price Target $66.75

Company Profile

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
BullYa
BullYa Jul. 29 at 5:54 PM
$TEM ✅opportunity 🛒↗️…
0 · Reply
AcceleratorModel
AcceleratorModel Jul. 29 at 4:55 PM
$TEM added 41s
0 · Reply
USMC223556
USMC223556 Jul. 29 at 4:54 PM
$TEM TEMPUS AI Know What You Own. A Company's Fundamentals, Business, and Potential Create Value. Investing Without Understanding What You Own Is Gambling.
0 · Reply
Stealyourstocks
Stealyourstocks Jul. 29 at 4:10 PM
$NOK $TEM $NOK WAR! What is it good for? Absolutely nuthin’! Even my decent albeit long positions are negative.
0 · Reply
anthealopez
anthealopez Jul. 29 at 3:43 PM
Bought more $SOFI $SMCI $TEM today!
0 · Reply
earlyretirmnt
earlyretirmnt Jul. 29 at 1:51 PM
$TEM a beat here resulting in a profitable quarter would be nice to see
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 29 at 12:33 PM
$AMLX Good Morning ☕️ $RXRX $SANA $TEM
0 · Reply
Hognose
Hognose Jul. 29 at 12:11 PM
$TEM one more quick drop and its a buy.
0 · Reply
GSP
GSP Jul. 29 at 11:51 AM
$TEM $LCID $QMLS $ADVB $SNDK
0 · Reply
Andrewsan85
Andrewsan85 Jul. 29 at 9:54 AM
$TEM direction until Friday’s close?
0 · Reply
Latest News on TEM
Tempus AI announces national launch of OneOme pharmacogenomics testing

2026-07-22T12:36:30.000Z - 7 days ago

Tempus AI announces national launch of OneOme pharmacogenomics testing

Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

Jul 22, 2026, 8:30 AM EDT - 7 days ago

Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

Personalis price target raised to $16.25 from $11 at BTIG

2026-07-21T10:41:24.000Z - 8 days ago

Personalis price target raised to $16.25 from $11 at BTIG

PSNL

Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a “Market Misread”

2026-07-20T20:18:32.000Z - 8 days ago

Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a “Market Misread”

PSNL

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

2026-07-20T18:45:13.000Z - 8 days ago

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

PSNL

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

2026-07-20T18:20:22.000Z - 8 days ago

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

AMTM GOOG GOOGL NVDA PSNL QMLS XMTR

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

2026-07-20T16:00:42.000Z - 9 days ago

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

AAPL ACHR AER AMC BA BABA BAM

Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink

Jul 20, 2026, 10:44 AM EDT - 9 days ago

Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink

PSNL

Personalis downgraded to Hold from Buy at Lake Street

2026-07-20T14:10:32.000Z - 9 days ago

Personalis downgraded to Hold from Buy at Lake Street

PSNL

Tempus AI Transcript: M&A announcement

Jul 20, 2026, 9:00 AM EDT - 9 days ago

Tempus AI Transcript: M&A announcement

Tempus AI Press release: M&A announcement

Jul 20, 2026, 9:00 AM EDT - 9 days ago

Tempus AI Press release: M&A announcement

Tempus AI Slides: M&A announcement

Jul 20, 2026, 9:00 AM EDT - 9 days ago

Tempus AI Slides: M&A announcement

Tempus to acquire Personalis for $1.5 billion

Jul 20, 2026, 8:44 AM EDT - 9 days ago

Tempus to acquire Personalis for $1.5 billion

PSNL

Tempus AI to acquire Personalis for $16.25 per share

2026-07-20T12:35:54.000Z - 9 days ago

Tempus AI to acquire Personalis for $16.25 per share

PSNL

Tempus AI to acquire Personalis for $16.25 per share

2026-07-20T12:35:19.000Z - 9 days ago

Tempus AI to acquire Personalis for $16.25 per share

PSNL

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

Jul 20, 2026, 8:30 AM EDT - 9 days ago

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

PSNL

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

Jul 16, 2026, 8:30 AM EDT - 13 days ago

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

Tempus AI price target raised to $65 from $60 at Guggenheim

2026-07-16T11:00:30.000Z - 13 days ago

Tempus AI price target raised to $65 from $60 at Guggenheim

Tempus AI price target raised to $71 from $68 at TD Cowen

2026-07-15T12:55:59.000Z - 14 days ago

Tempus AI price target raised to $71 from $68 at TD Cowen

Tempus to Report Second Quarter 2026 Financial Results on July 30

Jul 9, 2026, 9:00 AM EDT - 20 days ago

Tempus to Report Second Quarter 2026 Financial Results on July 30

Tempus AI initiated with a Hold at Freedom Capital

2026-06-30T20:35:12.000Z - 4 weeks ago

Tempus AI initiated with a Hold at Freedom Capital

Tempus AI announces research collaboration with Angiosarcoma Awareness

2026-06-25T12:35:24.000Z - 4 weeks ago

Tempus AI announces research collaboration with Angiosarcoma Awareness

Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Jun 25, 2026, 8:30 AM EDT - 4 weeks ago

Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms

Jun 16, 2026, 5:07 PM EDT - 6 weeks ago

Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms

Tempus AI announces publication of multi-center validation of software

2026-06-11T12:35:47.000Z - 6 weeks ago

Tempus AI announces publication of multi-center validation of software

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Jun 11, 2026, 8:30 AM EDT - 6 weeks ago

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Jun 9, 2026, 6:00 AM EDT - 7 weeks ago

Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Tempus AI Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 2:00 PM EDT - 7 weeks ago

Tempus AI Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Jun 5, 2026, 4:01 PM EDT - 7 weeks ago

Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members

Jun 3, 2026, 8:30 AM EDT - 2 months ago

Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

Jun 1, 2026, 8:30 AM EDT - 2 months ago

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development

May 31, 2026, 8:30 AM EDT - 2 months ago

Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

May 30, 2026, 8:30 AM EDT - 2 months ago

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

Tempus Introduces ‘Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

May 30, 2026, 8:00 AM EDT - 2 months ago

Tempus Introduces ‘Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

May 29, 2026, 9:15 AM EDT - 2 months ago

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

Tempus AI Transcript: Investor Day 2026

May 29, 2026, 9:00 AM EDT - 2 months ago

Tempus AI Transcript: Investor Day 2026

Tempus AI Slides: FY 2026

May 29, 2026, 9:00 AM EDT - 2 months ago

Tempus AI Slides: FY 2026

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

May 29, 2026, 8:15 AM EDT - 2 months ago

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

May 28, 2026, 8:30 AM EDT - 2 months ago

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

May 27, 2026, 8:33 AM EDT - 2 months ago

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

May 26, 2026, 8:30 AM EDT - 2 months ago

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

May 21, 2026, 8:30 AM EDT - 2 months ago

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

May 14, 2026, 8:30 AM EDT - 2 months ago

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

BMY

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

May 11, 2026, 6:00 AM EDT - 2 months ago

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

May 8, 2026, 12:59 AM EDT - 2 months ago

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

May 7, 2026, 7:11 AM EDT - 2 months ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

May 6, 2026, 8:00 AM EDT - 3 months ago

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

QTRX

Tempus AI Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Earnings Call Transcript: Q1 2026

Tempus AI Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Earnings release: Q1 2026

Tempus AI Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Slides: Q1 2026

Tempus AI Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Quarterly report: Q1 2026

Tempus Reports First Quarter 2026 Results

May 5, 2026, 4:01 PM EDT - 3 months ago

Tempus Reports First Quarter 2026 Results

Tempus to Host Inaugural Investor Day on May 29, 2026

Apr 29, 2026, 8:30 AM EDT - 3 months ago

Tempus to Host Inaugural Investor Day on May 29, 2026

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Apr 28, 2026, 8:30 AM EDT - 3 months ago

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Apr 23, 2026, 8:30 AM EDT - 3 months ago

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Tempus to Report First Quarter 2026 Financial Results on May 5

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Tempus to Report First Quarter 2026 Financial Results on May 5

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Apr 15, 2026, 8:30 AM EDT - 3 months ago

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 11:45 AM EDT - 3 months ago

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Apr 14, 2026, 8:30 AM EDT - 3 months ago

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Apr 13, 2026, 8:30 AM EDT - 3 months ago

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

GILD

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 4:01 PM EDT - 3 months ago

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Tempus AI Proxy statement: Proxy filing

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Tempus AI Proxy statement: Proxy filing

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Apr 1, 2026, 8:30 AM EDT - 4 months ago

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Mar 17, 2026, 8:30 AM EDT - 4 months ago

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Mar 11, 2026, 8:30 AM EDT - 5 months ago

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Mar 3, 2026, 12:15 PM EST - 5 months ago

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Mar 3, 2026, 8:30 AM EST - 5 months ago

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 26, 2026, 8:30 AM EST - 5 months ago

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Tempus AI Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

Tempus AI Earnings Call Transcript: Q4 2025

Tempus AI Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

Tempus AI Annual report: Q4 2025

Tempus AI Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

Tempus AI Earnings release: Q4 2025

Tempus AI Slides: Q4 2025

Feb 24, 2026, 4:30 PM EST - 5 months ago

Tempus AI Slides: Q4 2025

Tempus Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 4:01 PM EST - 5 months ago

Tempus Reports Fourth Quarter and Full Year 2025 Results

Is TEM Stock A Buy At $60?

Feb 19, 2026, 11:01 AM EST - 5 months ago

Is TEM Stock A Buy At $60?

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Feb 18, 2026, 8:30 AM EST - 5 months ago

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Feb 12, 2026, 4:05 PM EST - 5 months ago

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Feb 12, 2026, 4:05 PM EST - 5 months ago

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Feb 10, 2026, 8:30 AM EST - 6 months ago

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

BullYa
BullYa Jul. 29 at 5:54 PM
$TEM ✅opportunity 🛒↗️…
0 · Reply
AcceleratorModel
AcceleratorModel Jul. 29 at 4:55 PM
$TEM added 41s
0 · Reply
USMC223556
USMC223556 Jul. 29 at 4:54 PM
$TEM TEMPUS AI Know What You Own. A Company's Fundamentals, Business, and Potential Create Value. Investing Without Understanding What You Own Is Gambling.
0 · Reply
Stealyourstocks
Stealyourstocks Jul. 29 at 4:10 PM
$NOK $TEM $NOK WAR! What is it good for? Absolutely nuthin’! Even my decent albeit long positions are negative.
0 · Reply
anthealopez
anthealopez Jul. 29 at 3:43 PM
Bought more $SOFI $SMCI $TEM today!
0 · Reply
earlyretirmnt
earlyretirmnt Jul. 29 at 1:51 PM
$TEM a beat here resulting in a profitable quarter would be nice to see
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 29 at 12:33 PM
$AMLX Good Morning ☕️ $RXRX $SANA $TEM
0 · Reply
Hognose
Hognose Jul. 29 at 12:11 PM
$TEM one more quick drop and its a buy.
0 · Reply
GSP
GSP Jul. 29 at 11:51 AM
$TEM $LCID $QMLS $ADVB $SNDK
0 · Reply
Andrewsan85
Andrewsan85 Jul. 29 at 9:54 AM
$TEM direction until Friday’s close?
0 · Reply
Meril_Knoxville
Meril_Knoxville Jul. 29 at 8:06 AM
$TEM $USAR $MSTU $RDW $NBIL activate
0 · Reply
magnitudeFC
magnitudeFC Jul. 29 at 4:06 AM
$TEM why is stock based compensation so high here? Even by tech company standards it’s high 🤔
0 · Reply
TechWillCrash
TechWillCrash Jul. 29 at 1:29 AM
$GALT Do you any of you GALT shareholders who have knowledge of medical treatments have thoughts on this stock: $TEM ?
0 · Reply
Supersecret
Supersecret Jul. 29 at 12:17 AM
$TEM
0 · Reply
Meril_Knoxville
Meril_Knoxville Jul. 28 at 9:57 PM
If you missed the last runner, don't overlook APUS Tiny 623K float and still sitting under the radar! Stocktwits engagement is almost nonexistent... The biggest runners usually start when no one's watching💎 $JACK $TEM $JPM $XLV $TGTX <
1 · Reply
GSP
GSP Jul. 28 at 9:01 PM
Your Day Trading Watch List for July 29th in About 3 Minutes (con't): $TEM $LCID $QMLS $ADVB $SNDK .
0 · Reply
Meril_Knoxville
Meril_Knoxville Jul. 28 at 8:22 PM
$TEM $IGV $CBRS $INTW $TER back
0 · Reply
PencilNeckGeek
PencilNeckGeek Jul. 28 at 8:18 PM
$TEM Bottom in?
1 · Reply
Meril_Knoxville
Meril_Knoxville Jul. 28 at 7:44 PM
$FIG $CISS $TEM $FUTU $USO driving --
0 · Reply
I_am_back_2day
I_am_back_2day Jul. 28 at 7:01 PM
$TEM might end up green
0 · Reply
STRelativeWeakness
STRelativeWeakness Jul. 28 at 4:35 PM
$TEM crowded breakdown — 20,959 watchers along for the slide
0 · Reply